by Eric Christianson | Dec 13, 2013 | Cardiovascular Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
Elderly patient was on Amiodarone for treatment of chronic arrhythmia. Amiodarone has multiple clinical quirks and unique side effects associated with it. In my mind, it’s definitely a high risk/high reward type drug. The patient had begun to experience some shortness...
by Eric Christianson | Dec 3, 2013 | Long Term Care Consultant Pharmacist Education and Information, Medication and Disease State Clinical Pearls For Pharmacists, Psychiatry and Addiction Medication and Disease State Clinical Pearls
Alright, new topic…let’s roll…I’m going to tackle some psych tonight, because I always get asked questions about these meds! The topic of psych medications in general is very challenging to say the least, I believe it is much more of an art than science – i.e. when...
by Eric Christianson | Nov 30, 2013 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
I’m going to cover sulfonylureas tonight; this class is a mainstay in the treatment Type 2 diabetes. Other than metformin, these drugs are probably the most frequent oral class used. The most frequent names that come to mind are glipizide, glimepiride, and...
by Eric Christianson | Nov 29, 2013 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
Today, it’s the DDP-4 inhibitors! DPP-4 inhibitors can be expensive which may limit their use from time to time. These drugs work to increase the amount of incretin in the body. You can look back at my post on Byetta/Victoza which should be under the diabetes...
by Eric Christianson | Nov 27, 2013 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
I’m going to flip back to oral diabetes meds to cover a new agent that has recently been approved. It is a new class of diabetes med, but generally means it’s going to be quite expensive. This drug is Invokana (canagliflozin). It basically lowers glucose by causing an...
by Eric Christianson | Nov 26, 2013 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
Thanks to Sarah Taylor, Pharm.D. for her guest post tonight! Sliding scale insulin, or SSI, is commonly seen in nursing homes, however, it might suprise most healthcare workers to hear that this form of diabetes “management” is not considered best...
